Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

J&J Innovative Medicine Medical AffairsJ&J Innovative Medicine Medical Affairs
VS
ParexelParexel
J&J Innovative Medicine Medical Affairs

J&J Innovative Medicine Medical Affairs

920 US-202, Raritan, New Jersey, US, 08869

Last Update: 22/04/2026

View Profile
749/1000Moderate

The goal of the J&J Innovative Medicine Medical Affairs LinkedIn page is to share oncology, immunology, and neuroscience-related medical & scientific information with US healthcare professionals (HCPs). We will share information about scientific data presented at medica...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:2
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Parexel

Parexel

541 Church at North Hills St, 1000, Raleigh, North Carolina, US, 27609

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.parexel.com
794/1000Fair

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, ou...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:20,434
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
J&J Innovative Medicine Medical Affairs

J&J Innovative Medicine Medical Affairs

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Parexel

Parexel

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for J&J Innovative Medicine Medical Affairs in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Parexel in 2026.

Incidents

Incident History - J&J Innovative Medicine Medical Affairs (X = Date, Y = Severity)

J&J Innovative Medicine Medical Affairs cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Parexel (X = Date, Y = Severity)

Parexel cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
J&J Innovative Medicine Medical Affairs

J&J Innovative Medicine Medical Affairs

Incidents
No explicit notable incidents reported.
Parexel

Parexel

Incidents
🔒 Incident : Vulnerability
ORAPAR1766015901

FAQ

Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has the best AI Cybersecurity Score ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has experienced more cyber incidents in the past ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has experienced more cyber incidents this year ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has experienced at least one ransomware attack ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has experienced at least one data breach ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has experienced at least one targeted cyberattack ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has experienced at least one vulnerability ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one holds the most compliance certifications ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one holds the fewest compliance certifications ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has the most subsidiaries ?
Between J&J Innovative Medicine Medical Affairs company and Parexel company, which one has the largest number of employees ?
Between J&J Innovative Medicine Medical Affairs and Parexel, which company holds both SOC 2 Type 1 certifications ?
Between J&J Innovative Medicine Medical Affairs and Parexel, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - J&J Innovative Medicine Medical Affairs or Parexel ?
Which company is PCI DSS compliant - J&J Innovative Medicine Medical Affairs or Parexel ?
Between J&J Innovative Medicine Medical Affairs and Parexel, which company complies with HIPAA regulations for healthcare data ?
Between J&J Innovative Medicine Medical Affairs and Parexel, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-16197
SUMMARY

A security vulnerability has been detected in Sipeed PicoClaw up to 0.2.9. The affected element is the function handleMessageReceive of the file pkg/channels/feishu/feishu_64.go of the component Group Message Handler. Such manipulation leads to missing authorization. The attack can be launched remotely. The exploit has been disclosed publicly and may be used. The reported GitHub issue was closed automatically due to inactivity.

PUBLISHED
Date2026-07-18
UPDATED
Date2026-07-18
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-16196
SUMMARY

A weakness has been identified in Sipeed PicoClaw up to 0.2.9. Impacted is the function isPrivateOrRestrictedIP of the file pkg/tools/integration/web.go of the component web_fetch. This manipulation causes server-side request forgery. The attack can be initiated remotely. The exploit has been made available to the public and could be used for attacks. Patch name: 2efbe5d560e7ed9bc5209c203dc4aa6ecdbc7405. To fix this issue, it is recommended to deploy a patch.

PUBLISHED
Date2026-07-18
UPDATED
Date2026-07-18
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-16195
SUMMARY

A security flaw has been discovered in Sipeed PicoClaw up to 0.2.9. This issue affects the function dispatchIncoming of the file pkg/channels/wecom/wecom.go of the component Group Message Handler. The manipulation results in incorrect authorization. It is possible to launch the attack remotely. The exploit has been released to the public and may be used for attacks. The reported GitHub issue was closed automatically due to inactivity.

PUBLISHED
Date2026-07-18
UPDATED
Date2026-07-18
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-10130
SUMMARY

QueryWeaver contains an authentication bypass vulnerability that allows unauthenticated attackers to obtain valid session tokens for existing accounts by submitting a signup request with a known victim email address. The signup route unconditionally creates and links a new token to the matching Identity via a Cypher MERGE operation before checking whether the email belongs to an existing account, causing the server to return a valid authenticated session token for the victim's identity without requiring any prior credentials or user interaction.

PUBLISHED
Date2026-07-18
UPDATED
Date2026-07-18
RISK INFORMATION (Score: 8.2)
CVSS3
Base Score: 8.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.2
EXPLOITABILITY
3.9
CVE-2026-16194
SUMMARY

A vulnerability was determined in zhayujie CowAgent up to 2.1.1. This affects the function WebFetch.execute of the file agent/tools/web_fetch/web_fetch.py. Executing a manipulation of the argument url can lead to server-side request forgery. The attack may be performed from remote. The exploit has been publicly disclosed and may be utilized. Upgrading to version 2.1.2 is able to mitigate this issue. This patch is called ea47f3097eed4f8295c4cb3d76ecb97e0f43d632. It is recommended to upgrade the affected component. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.

PUBLISHED
Date2026-07-18
UPDATED
Date2026-07-18
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8